Evaluation of the Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma: A Prospective Multicenter Observational Study to Differentiate Pancreatic Cancer From Chronic Pancreatitis and Mucinous Pancreatic Lesions

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07875582

Title field or adapter rule

{'original_value': 'Evaluation of the Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma: A Prospective Multicenter Observational Study to Differentiate Pancreatic Cancer From Chronic Pancreatitis and Mucinous Pancreatic Lesions', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:23.158505+00:00

Published At

2026-10-19T00:00:00+00:00

Record Updated At

2026-10-19

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Cancer", "Chronic Pancreatitis", "Intraductal Papillary Mucinous Neoplasm", "Mucinous Cystic Neoplasm"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-19", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07875582"

protocolSection.identificationModule.officialTitle

"Evaluation of the Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma: A Prospective Multicenter Observational Study to Differentiate Pancreatic Cancer From Chronic Pancreatitis and Mucinous Pancreatic Lesions"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

null

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Cancer (protocolSection.conditionsModule.conditions)
• Chronic Pancreatitis (protocolSection.conditionsModule.conditions)
• Intraductal Papillary Mucinous Neoplasm (protocolSection.conditionsModule.conditions)
• Mucinous Cystic Neoplasm (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Chronic Pancreatitis', 'Intraductal Papillary Mucinous Neoplasm (IPMN)', 'Mucinous Cystic Neoplasm (MCN)', 'Pancreatic Ductal Adenocarcinoma (PDAC)'], 'description': 'Blood samples will be collected for the measurement of circulating protein biomarkers, including GDF-15, ICAM-1, osteopontin, CXCL10, HGF, Nectin-4, periostin, and VEGF-A, using a validated Luminex-based multiplex assay. CA 19-9 levels will also be assessed. Biomarker concentrations will be compared across the four diagnostic groups to evaluate their ability to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis and mucinous pancreatic lesions.', 'name': 'Blood-Based Protein Biomarker Assessment', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.